These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

987 related items for PubMed ID: 29912484

  • 1. In vitro Activity of Sitafloxacin and Other Antibiotics against Bacterial Isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital.
    Tantisiriwat W, Linasmita P.
    J Med Assoc Thai; 2017 Apr; 100(4):469-78. PubMed ID: 29912484
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.
    Tiengrim S, Phiboonbanakit D, Thunyaharn S, Tantisiriwat W, Santiwatanakul S, Susaengrat W, Srisurat N, Malithong A, Srisangchan P, Thamlikitkul V.
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S6-17. PubMed ID: 22574524
    [Abstract] [Full Text] [Related]

  • 3. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
    Hamouche E, Sarkis DK.
    Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
    [Abstract] [Full Text] [Related]

  • 4. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D, Gülay Z, Akan OA, Aktaş Z, Kayacan CB, Cakici O, Eraç B, Gültekin M, Oğünç D, Söyletir G, Unal N, Uysal S.
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [Abstract] [Full Text] [Related]

  • 5. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P, Hasçelik G, Unal S.
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [Abstract] [Full Text] [Related]

  • 6. In vitro susceptibility test of sitafloxacin against resistant gram-negative bacilli isolated from Thai patients by disk diffusion method.
    Thamlikitkul V, Tiengrim S.
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S7-12. PubMed ID: 24772575
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex.
    Huang YS, Wang JT, Sheng WH, Chuang YC, Chang SC.
    J Microbiol Immunol Infect; 2015 Oct; 48(5):545-51. PubMed ID: 24662017
    [Abstract] [Full Text] [Related]

  • 8. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
    Ishikawa K, Hamasuna R, Uehara S, Yasuda M, Yamamoto S, Hayami H, Takahashi S, Matsumoto T, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Deguchi T, Matsumoto M, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Wakeda H, Amemoto Y, Onodera S, Goto H, Komeda H, Yamashita M, Takenaka T, Fujimoto Y, Tsugawa M, Takahashi Y, Maeda H, Onishi H, Ishitoya S, Nishimura K, Mitsumori K, Ito T, Togo Y, Nakamura I, Ito N, Kanamaru S, Hirose T, Muranaka T, Yamada D, Ishihara S, Oka H, Inatomi H, Matsui T, Kobuke M, Kunishima Y, Kimura T, Ichikawa T, Kagara I, Matsukawa M, Takahashi K, Mita K, Kato M, Okumura K, Kawanishi H, Hashimura T, Aoyama T, Shigeta M, Koda S, Taguchi K, Matsuda Y.
    J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
    [Abstract] [Full Text] [Related]

  • 9. Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies.
    Grillon A, Schramm F, Kleinberg M, Jehl F.
    PLoS One; 2016 Sep; 11(6):e0156690. PubMed ID: 27257956
    [Abstract] [Full Text] [Related]

  • 10. Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
    Zhang H, Yang Q, Liao K, Ni Y, Yu Y, Hu B, Sun Z, Huang W, Wang Y, Wu A, Feng X, Luo Y, Chu Y, Chen S, Cao B, Su J, Duan Q, Zhang S, Shao H, Kong H, Gui B, Hu Z, Badal R, Xu Y.
    BMC Infect Dis; 2017 Dec 18; 17(1):776. PubMed ID: 29254478
    [Abstract] [Full Text] [Related]

  • 11. Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013.
    Jean SS, Coombs G, Ling T, Balaji V, Rodrigues C, Mikamo H, Kim MJ, Rajasekaram DG, Mendoza M, Tan TY, Kiratisin P, Ni Y, Weinman B, Xu Y, Hsueh PR.
    Int J Antimicrob Agents; 2016 Apr 18; 47(4):328-34. PubMed ID: 27005459
    [Abstract] [Full Text] [Related]

  • 12. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW, Woerther PL, Soussy CJ, Fines-Guyon M, Dowzicky MJ.
    Antimicrob Resist Infect Control; 2018 Apr 18; 7():68. PubMed ID: 29876099
    [Abstract] [Full Text] [Related]

  • 13. Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016.
    Kuo SC, Liu CE, Lu PL, Chen YS, Lu MC, Ko WC, Hsueh PR, Chuang YC, Wang FD, SMART Asia-Pacific Group.
    Int J Antimicrob Agents; 2020 Mar 18; 55(3):105883. PubMed ID: 31923574
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z, Kayacan C, Oncul O.
    Int J Antimicrob Agents; 2012 Jan 18; 39(1):86-9. PubMed ID: 22041508
    [Abstract] [Full Text] [Related]

  • 15. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia.
    Kader AA, Angamuthu K.
    Saudi Med J; 2005 Jun 18; 26(6):956-9. PubMed ID: 15983682
    [Abstract] [Full Text] [Related]

  • 16. The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms.
    Chang PC, Chen CC, Lu YC, Lai CC, Huang HL, Chuang YC, Tang HJ.
    J Microbiol Immunol Infect; 2018 Apr 18; 51(2):207-213. PubMed ID: 29037802
    [Abstract] [Full Text] [Related]

  • 17. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M.
    Int J Infect Dis; 2008 May 18; 12(3):256-64. PubMed ID: 17981482
    [Abstract] [Full Text] [Related]

  • 18. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W, Tantichattanon W, Wongwatcharapaiboon S, Treeratweeraphong V.
    J Med Assoc Thai; 2008 Oct 18; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [Abstract] [Full Text] [Related]

  • 19. [In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010].
    Yamaguchi K, Ohno A, Ishii Y, Tateda K, Iwata M, Levofloxacin-Surveillance Group.
    Jpn J Antibiot; 2012 Jun 18; 65(3):181-206. PubMed ID: 23173294
    [Abstract] [Full Text] [Related]

  • 20. In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates.
    Sutherland CA, Verastegui JE, Nicolau DP.
    Ann Clin Microbiol Antimicrob; 2016 Jun 17; 15(1):39. PubMed ID: 27316973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.